The purpose of this study is to compare the effects of varying dosage of coenzyme Q10 (CoQ10)
versus a placebo in the treatment of Parkinson's disease (PD) in patients with early,
untreated PD.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)